PetMed Express, Inc. (PETS) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

PetMed Express, Inc. (PETS) Healthcare & Pipeline Overview

PetMed Express, Inc. (PETS) is a pet pharmacy in the U.S., offering prescription and non-prescription medications, health products, and supplies for pets. The company distributes its products through online and offline channels, facing competition in a growing but fragmented pet medication market.

What Is the Investment Thesis for PETS?

PetMed Express, Inc. faces challenges given its negative profit margin of -35.5% and a market capitalization of $36.3M. The company's gross margin stands at 29.0%. Growth catalysts include expanding its online presence and leveraging its established brand recognition. However, increasing competition from both online and brick-and-mortar retailers, along with evolving consumer preferences, pose significant risks. Investors should closely monitor the company's ability to improve profitability and adapt to the changing market dynamics in the pet medication industry.

Based on FMP financials and quantitative analysis

PETS Key Highlights

Market Cap: $36.3M, reflecting its small size within the pet pharmaceutical industry.

• Profit Margin: -35.5%, indicating significant challenges in achieving profitability.
• Gross Margin: 29.0%, showing the percentage of revenue exceeding the cost of goods sold.
• Beta: 0.78, suggesting lower volatility compared to the overall market.
• Dividend Yield: None, indicating that the company does not currently distribute dividends to shareholders.

Who Are PETS's Competitors?

PETS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are PETS's Key Strengths?

Established brand recognition.

• Direct-to-consumer distribution.
• Wide range of products.
• Convenient online platform.

What Are PETS's Weaknesses?

Negative profit margin.

• High marketing expenses.
• Dependence on prescription approvals.
• Intense competition.

What Could Drive PETS Stock Higher?

Expansion of online platform and mobile app capabilities to enhance customer experience.

• Potential partnerships with veterinary clinics to expand customer reach.
• Introduction of new private label products to improve profit margins.
• Marketing campaigns to increase brand awareness and customer acquisition.

What Are the Key Risks for PETS?

Financial-distress signal — its Altman Z-Score of 1.40 sits in the distress zone (elevated bankruptcy risk).

• Inconsistent delivery — missed Wall Street EPS estimates in 7 of the last 8 reported quarters.
• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• Increasing competition from online and brick-and-mortar retailers.
• Regulatory changes affecting the sale of pet medications.
• Economic downturns impacting consumer spending on pet products.
• Fluctuations in marketing expenses and customer acquisition costs.

What Are the Growth Opportunities for PETS?

• Expansion of Telehealth Services: PetMed Express can leverage telehealth to offer virtual consultations and prescription services, tapping into the growing demand for convenient pet healthcare solutions. The telehealth market is projected to reach $17.4 billion by 2027. By integrating telehealth, PetMed Express can enhance customer engagement and expand its service offerings, potentially increasing revenue and customer loyalty.
• Strategic Partnerships with Veterinary Clinics: Collaborating with veterinary clinics can provide PetMed Express with access to a broader customer base and enhance its credibility. These partnerships can involve offering discounts to clinic clients or integrating PetMed Express's services into the clinic's workflow. This strategy can drive customer acquisition and increase prescription fulfillment rates, contributing to revenue growth.
• Enhancement of Mobile App and Online Platform: Improving the user experience of its mobile app and online platform can drive customer engagement and sales. This includes features such as personalized product recommendations, easy prescription refills, and streamlined checkout processes. A user-friendly platform can attract and retain customers, leading to increased online sales and customer lifetime value.
• Development of Private Label Products: Introducing private label pet medications and supplies can improve profit margins and differentiate PetMed Express from competitors. These products can be offered at competitive prices while maintaining quality, attracting price-sensitive customers and increasing brand loyalty. The private label market is growing, offering PetMed Express an opportunity to enhance profitability and market share.
• Geographic Expansion into Underserved Markets: Expanding into new geographic markets within the United States can drive revenue growth. Identifying regions with high pet ownership rates and limited access to pet pharmacies can provide PetMed Express with a competitive advantage. This expansion can be achieved through targeted marketing campaigns and strategic partnerships with local veterinary clinics and pet organizations.

What Are PETS's Competitive Advantages?

• Established brand recognition with the 1-800-PetMeds brand.
• Direct-to-consumer distribution model.
• Wide range of prescription and non-prescription products.
• Convenient online and mobile shopping experience.

What Does PETS Do?

PetMed Express, Inc., incorporated in 1996 and headquartered in Delray Beach, Florida, operates as a pet pharmacy in the United States. The company markets a wide array of prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. Its product offerings include non-prescription medications and supplies such as flea and tick control, bone and joint care, vitamins, treats, nutritional supplements, and hygiene products. Additionally, it provides prescription medications including heartworm preventatives, arthritis treatments, dermatitis solutions, thyroid medications, diabetes management, pain relief, heart/blood pressure medications, and generic substitutes. PetMed Express sells its products through its Internet website, mobile app, telephone contact center, and direct mail/print, including brochures, postcards, and television advertising under the 1-800-PetMeds and PetMeds brands. The company aims to provide convenient access to pet medications and supplies, catering to pet owners' needs across the United States.

What Products and Services Does PETS Offer?

• Sells prescription and non-prescription pet medications.
• Offers health products and supplies for dogs, cats, and horses.
• Provides flea and tick control products.
• Markets bone and joint care products and vitamins.
• Sells treats and nutritional supplements.
• Offers hygiene products and pet supplies.
• Distributes products through its website, mobile app, and telephone contact center.
• Utilizes direct mail and television advertising for marketing.

How Does PETS Make Money?

• Sells pet medications and supplies directly to consumers.
• Generates revenue through online and offline sales channels.
• Fulfills prescription orders with veterinarian authorization.
• Markets products through advertising and promotional campaigns.

What Industry Does PETS Operate In?

PetMed Express operates within the medical pharmaceutical industry, specifically focusing on pet medications and supplies. The market is characterized by increasing pet ownership and spending on pet health. Competition includes online retailers, brick-and-mortar pet stores, and veterinary clinics. The industry is driven by trends such as pet humanization and the rising demand for specialized pet healthcare products. PetMed Express competes by offering a wide range of products and convenient purchasing options.

Who Are PETS's Key Customers?

• Pet owners seeking convenient access to medications and supplies.
• Owners of dogs, cats, and horses.
• Customers who prefer online and mobile shopping.
• Individuals looking for cost-effective pet healthcare solutions.

Over the past six months, PetMed Express, Inc. insiders filed 7 SEC Form 4 transactions — 0 sales and 7 purchases. On net that is roughly 317K shares acquired (about $44K) — insiders putting money in tends to read as conviction.

PetMed Express, Inc. has missed Wall Street's EPS estimate in 7 of its last 8 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 473.2% below estimates on average.

PetMed Express, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 1.40 places it in the distress zone, a signal of elevated financial risk.

Key Financial Metrics

Return on assets is -70.6%, showing how much profit it generates from its asset base. Its free cash flow yield is -86.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.84 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -152.2%, the inverse of the P/E and a quick read on earnings relative to price.

PetMed Express, Inc. (PETS) Valuation Context

Valued at $36.3M, PETS is classified as a micro-cap stock. Relative to its peer group, PETS's quantitative score of 33/100 is below the peer average of 50/100.

PETS Revenue & Earnings Trend

In Q1 FY2027, PETS generated $41.0M in top-line revenue, marking a sequential decrease of 4.2%. The company recorded a net loss of $6.1M, with diluted EPS of $-0.28. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, PETS averaged $-0.35 in diluted EPS.

Company Profile

PetMed Express, Inc. operates in the Specialty Retail industry within the Consumer Cyclical sector. It is headquartered in Delray Beach, US. The company is led by CEO Leslie C. G. Campbell. PETS has traded publicly since 1999.

PETS Financials

PETS Latest News

PETS Analyst Consensus

PETS MoonshotScore

Common Questions About PETS (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources